180 related articles for article (PubMed ID: 28888575)
1. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
[TBL] [Abstract][Full Text] [Related]
2. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
Yu AS; Zhao L
Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
[TBL] [Abstract][Full Text] [Related]
4. Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.
Mahgoub T; Eustace AJ; Collins DM; Walsh N; O'Donovan N; Crown J
Int J Oncol; 2015 Sep; 47(3):900-8. PubMed ID: 26201960
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
6. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.
Liu Y; Xi L; Liao G; Wang W; Tian X; Wang B; Chen G; Han Z; Wu M; Wang S; Zhou J; Xu G; Lu Y; Ma D
BMC Cancer; 2007 Jan; 7():22. PubMed ID: 17261172
[TBL] [Abstract][Full Text] [Related]
8. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
Yan H; Tong J; Lin X; Han Q; Huang H
Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
[TBL] [Abstract][Full Text] [Related]
9. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo.
Lin J; Yan XJ; Chen HM
Cancer Chemother Pharmacol; 2007 Mar; 59(4):439-45. PubMed ID: 16816972
[TBL] [Abstract][Full Text] [Related]
10. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
11. Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.
Shirali S; Aghaei M; Shabani M; Fathi M; Sohrabi M; Moeinifard M
Tumour Biol; 2013 Apr; 34(2):1085-95. PubMed ID: 23345014
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
Mahale S; Aubry C; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
Bioorg Chem; 2006 Oct; 34(5):287-97. PubMed ID: 16904725
[TBL] [Abstract][Full Text] [Related]
13. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.
Gao M; Ma Y; Bast RC; Li Y; Wan L; Liu Y; Sun Y; Fang Z; Zhang L; Wang X; Wei Z
Med Oncol; 2016 Jul; 33(7):73. PubMed ID: 27277757
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.
Shen YY; Yuan Y; Du YY; Pan YY
Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368
[TBL] [Abstract][Full Text] [Related]
16. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
18.
Qiu ZH; Zhang WW; Zhang HH; Jiao GH
World J Gastroenterol; 2019 May; 25(20):2463-2472. PubMed ID: 31171890
[TBL] [Abstract][Full Text] [Related]
19. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
[TBL] [Abstract][Full Text] [Related]
20. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
Li J; Jiang K; Zhao F
Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
